UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000026034
Receipt No. R000029920
Official scientific title of the study Concurrent chemoradiotherapy with paclitaxel and carboplatin for stage III or IVA cervical cancer with renal dysfunction
Date of disclosure of the study information 2017/04/01
Last modified on 2017/02/07 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Concurrent chemoradiotherapy with paclitaxel and carboplatin for stage III or IVA cervical cancer with renal dysfunction
Title of the study (Brief title) CCRT with TC for cervical cancer
Region
Japan

Condition
Condition Locally advanced stage III or IVA cervical cancer with renal dysfunction
Classification by specialty
Obsterics and gynecology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate safety and efficacy of CCRT with TC
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Cancellation rate by adverse events
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Radiotherapy and chemotherapy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria Patients diagnosed stage III or IVA cervical cancer with renal dysfunction (eGFR is less than 60)
Key exclusion criteria Patients treated with paclitaxel or carboplatin previously
Target sample size 32

Research contact person
Name of lead principal investigator Yuichi Imai
Organization Yokohama City University Hospital
Division name Department of Obstetrics and gynecology
Address 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa 236-0004, Japan
TEL 045-787-2800
Email you11sep@gmail.com

Public contact
Name of contact person Yuichi Imai
Organization Yokohama City University Hospital
Division name Department of Obstetrics and gynecology
Address 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa 236-0004, Japan
TEL 045-787-2800
Homepage URL
Email you11sep@gmail.com

Sponsor
Institute Yokohama City University
Institute
Department

Funding Source
Organization Yokohama City University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 04 Month 01 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 01 Month 20 Day
Anticipated trial start date
2017 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 02 Month 07 Day
Last modified on
2017 Year 02 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029920